ModernaMRNA 
$69.68-12.36%24h
-12.36%24h
Global rank679
Market cap$26.57B
Change 7d-5.17%
YTD Performance-30.24%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Moderna (MRNA)
As of September 2024, Moderna has a market cap of $26.57B. This makes Moderna the world's 679th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Moderna from 2018 to 2024
-
Value:-
Market cap history of Moderna from 2018 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $34.62B | -8.69% |
| 2023 | $37.92B | -44.63% |
| 2022 | $68.49B | -29.28% |
| 2021 | $96.84B | 143.11% |
| 2020 | $39.83B | 434.10% |
| 2019 | $7.46B | 28.09% |
| 2018 | $5.82B | - |
MRNA Market Cap Today is $26.57B -12.36% - 14 Sept 2024
View largest stocks by market cap 
